Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06731426

Effects of Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion in Adults with Obsessive-Compulsive Symptoms: a Randomized Controlled Trial

Led by Han Joo Lee · Updated on 2024-12-12

84

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

H

Han Joo Lee

Lead Sponsor

P

Psi Chi

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a cognitive bias modification called Thought-Action-Fusion (TAF) which is a thinking pattern linking unwanted thoughts to moral wrongdoing or increased likelihood of those thoughts happening. This pattern is important in obsessive-compulsive disorder (OCD). The study aims to test whether a multi-session, personalized training can reduce obsessive-compulsive symptoms in a college-aged adult group. Participants will be randomly assigned to one of three groups: CBM-TAF, CBM-SMP (stress management psychoeducation), or a waitlist group. Those in the CBM-TAF and CBM-SMP groups will complete six training sessions over three weeks (twice a week), each lasting about 20 minutes. The sessions involve an ambiguous sentence-completion task and watching brief animated videos related to TAF or stress management. The waitlist group only completes weekly assessments without training. All participants will take assessments before training, after completing six sessions, and again one month later. These include measuring thought-action-fusion levels, obsessive-compulsive symptoms, and depression, anxiety, and stress. The entire study is conducted via a mobile web platform allowing participants to complete training and assessments remotely. The study will monitor changes over time to assess the training's impact on OCD-related thoughts and symptoms.

CONDITIONS

Brief Title

Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A score of 18 or higher on the Dimensional Obsessive-Compulsive Scale (DOCS)
  • Aged 18 years or older
  • Access to a mobile device such as a smartphone
Not Eligible

You will not qualify if you...

  • Visual impairment that cannot be adjusted and prevents clear recognition of words and pictures on a mobile screen
  • History of bipolar disorder or psychotic disorder
  • Inability to understand study procedures based on comprehension questions at consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (online)

Treatment

Duration - 3 weeks

Participants randomized to the training groups complete 6 sessions of cognitive bias modification (CBM-TAF or CBM-SMP) over 3 weeks, with 2 sessions per week. Each session includes watching a brief animated video followed by completing a sentence-completion task. Participants in the waitlist group complete weekly assessments without training sessions.

6 online sessions (2 per week)

Follow-up

Duration - 1 month

Participants complete assessments 1 month after the end of the training period to evaluate lasting effects of the intervention.

1 online assessment visit

Trial Site Locations

Total: 1 location

1

UWM Anxiety Disorders Laboratory

Milwaukee, Wisconsin, United States, 53211

Actively Recruiting

Loading map...

Research Team

H

Hanjoo Lee, PhD

M

Minjee Kook, BA

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Behavioural Development, Long-term Outcomes and Opportunitie...

Depression - Major Depressive Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale.

Jonathan S Abramowitz, Brett J Deacon, Bunmi O Olatunji...

https://pubmed.ncbi.nlm.nih.gov/20230164

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.

P F Lovibond, S H Lovibond

https://pubmed.ncbi.nlm.nih.gov/7726811